Healthcare provider profile · identity verified

Todd William Engstrom, MD

Internal Medicine · CARPINTERIA, CA · NPI 1538282587

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	517	161
Amlodipine Besylate	Amlodipine Besylate	417	127
Levothyroxine Sodium	Levothyroxine Sodium	393	110
Losartan Potassium	Losartan Potassium	347	112
Lisinopril	Lisinopril	273	89
Rosuvastatin Calcium	Rosuvastatin Calcium	222	65
Tamsulosin Hcl	Tamsulosin Hcl	188	59
Simvastatin	Simvastatin	174	46
Hydrochlorothiazide	Hydrochlorothiazide	173	54
Omeprazole	Omeprazole	166	58
Metoprolol Succinate	Metoprolol Succinate	163	57
Gabapentin	Gabapentin	160	48
Eliquis	Apixaban	133	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	117	31
Zolpidem Tartrate	Zolpidem Tartrate	116	41
Lorazepam	Lorazepam	113	24
Escitalopram Oxalate	Escitalopram Oxalate	109	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	105	24
Alprazolam	Alprazolam	104	37
Famotidine	Famotidine	103	43
Metformin Hcl	Metformin Hcl	100	32
Furosemide	Furosemide	97	36
Potassium Chloride	Potassium Chloride	81	25
Ezetimibe	Ezetimibe	69	20
Pravastatin Sodium	Pravastatin Sodium	69	18
Allopurinol	Allopurinol	64	22
Mirtazapine	Mirtazapine	64	13
Metformin Hcl Er	Metformin Hcl	59	18
Carvedilol	Carvedilol	58	22
Trazodone Hcl	Trazodone Hcl	58	20
Quetiapine Fumarate	Quetiapine Fumarate	57	11
Clonazepam	Clonazepam	55	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	18
Metoprolol Tartrate	Metoprolol Tartrate	54	19
Albuterol Sulfate Hfa	Albuterol Sulfate	53	20
Donepezil Hcl	Donepezil Hcl	53	12
Xarelto	Rivaroxaban	52	14
Synthroid	Levothyroxine Sodium	51	14
Atenolol	Atenolol	48	12
Azithromycin	Azithromycin	47	37
Tramadol Hcl	Tramadol Hcl	47	14
Jardiance	Empagliflozin	46	12
Benazepril Hcl	Benazepril Hcl	45	12
Finasteride	Finasteride	44	15
Pantoprazole Sodium	Pantoprazole Sodium	43	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	11
Sertraline Hcl	Sertraline Hcl	40	12
Ozempic	Semaglutide	38	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Valacyclovir	Valacyclovir Hcl	38	19
Valsartan	Valsartan	38	14
Fluticasone Propionate	Fluticasone Propionate	36	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	14
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	14
Fluoxetine Hcl	Fluoxetine Hcl	32	12
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	31	suppressed
Repatha Sureclick	Evolocumab	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Midodrine Hcl	Midodrine Hcl	26	suppressed
Cephalexin	Cephalexin	24	19
Digoxin	Digoxin	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	20
Acyclovir	Acyclovir	21	suppressed
Diazepam	Diazepam	21	11
Buspirone Hcl	Buspirone Hcl	20	suppressed
Praluent Pen	Alirocumab	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Celecoxib	Celecoxib	19	11
Estradiol	Estradiol	19	11
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Folic Acid	Folic Acid	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	15
Montelukast Sodium	Montelukast Sodium	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Propranolol Hcl	Propranolol Hcl	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Ramipril	Ramipril	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Temazepam	Temazepam	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Dutasteride	Dutasteride	13	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error